|
|
|
AHFS¢ç Drug Information¢ç 2019 |
|
|
|
|
¡ØÇØ¿ÜÁÖ¹® µµ¼ ¾È³» :
- ÇØ¿Ü ¹× ±¹³» ÀÔ°í »çÇ׿¡ µû¶ó 2~8ÁÖ ÀÌ»ó ¼Ò¿äµÉ ¼ö ÀÖÀ¸¸ç. Ãë¼Ò ¹× ¹ÝÇ°ÀÌ ºÒ°¡´ÉÇÕ´Ï´Ù. - ÇØ¿ÜÁÖ¹®µµ¼´Â ÇØ¿Ü ÃâÆÇ»ç »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ¼ö ÀÖ½À´Ï´Ù. |
|
¡Ø±³È¯ ¹× ¹ÝÇ°¾È³» :
- ±³È¯À̳ª ¹ÝÇ°½Ã »óÇ° ¼ö·ÉÈÄ 3ÀÏÀ̳» ±³È¯À̳ª ¹ÝÇ° Àǻ縦 ¾Ë·ÁÁֽðí ÀÏÁÖÀÏÀ̳»¿¡ ÀúÈñÂÊÀ¸·Î »óÇ°ÀÌ ÀÔ°íµÇ¾î¾ßÇÕ´Ï´Ù. ½ÃÀÏÀÌ °æ°úµÇ¸é ¹ÝÇ°ÀÌ ºÒ°¡ÇÕ´Ï´Ù. - º¯½É¿¡ ÀÇÇÑ ±³È¯À̳ª ¹ÝÇ°½Ã, ¹è¼Ûºñ´Â °í°´´Ô²²¼ ºÎ´ãÇϽøç, ¿À¹è¼ÛÀ̳ª »óÇ° ºÒ·®½Ã¿¡´Â ¹«·á ±³È¯ÀÌ °¡´ÉÇÕ´Ï´Ù. - ¹ÝÇ°½Ã¿¡´Â ¹ÝÇ°»óÇ° °Ë¼öÈÄ Ä«µå Ãë¼Ò¸¦ Çص帮°Å³ª ÅëÀå,Àû¸³±ÝµîÀ¸·Î ȯºÒ Á¶Ä¡ ÇØ µå¸³´Ï´Ù. |
|
¡Ø¹è¼Û¾È³» :
- Á¦ÁÖµµ¹× µµ¼»ê°£Áö¿ªÀº Åùèºñ°¡ Ãß°¡µÉ¼ö ÀÖ½À´Ï´Ù. |
|
|
|
|
|
|
|
|
|
¡¡With extensive updated information on everything from treatment of chronic pain to management of HIV infection in paediatric patients, AHFS¢ç Drug Information¢ç 2019 is a necessary addition to your pharmacy's resources.
¡¡With content supported by nearly 90,000 references and incorporating the advice of numerous subject matter experts, AHFS¢ç Drug Information¢ç 2019 helps you protect your patients and your practice. It is the only reference published by an American professional and scientific society–ensuring it is the most authoritative and best-selling reference trusted by pharmacists for over 60 years.
¡¡AHFS¢ç Drug Information¢ç 2019 contains the most trustworthy drug information available–all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
¡¡¡¡Updates for this edition include:
¡¡¡¡¡¡¤ý¡¡Expanded and revised content throughout, featuring critical new monograph updates every year
¡¡¡¡¡¡¤ý¡¡Important updated monographs and references related to revised therapeutic guidelines, including revised recommendations for treatment of fungal infections (such as Candida auris infections) and chronic hepatitis C
¡¡¡¡¡¡¤ý¡¡Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program
¡¡¡¡¡¡¤ý¡¡Dedicated coverage to orphan products
¡¡¡¡¡¡¤ý¡¡Interactions, adverse reactions, and cautions, including ongoing revisions addressing opiate safety issues and their role in pain management
¡¡¡¡¡¡¤ý¡¡Therapeutic recommendations supported by evidence from primary research
¡¡¡¡¡¡¤ý¡¡Extensive dosage and administration information
¡¡¡¡¡¡¤ý¡¡Pharmacology and pharmacokinetics
¡¡¡¡¡¡¤ý¡¡Prescription, OTC, ophthalmic and dermatologic drugs
¡¡¡¡¡¡¤ý¡¡Extensive off-label uses and related dosing options
¡¡¡¡¡¡¤ý¡¡Vaccines and other immunizing agents, including recommendations for travellers
|
|
|
|
|
|
|
|
|
|
|
µî·ÏµÈ ¼ÆòÀÌ ¾ø½À´Ï´Ù. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|